Evidence map›Paper›PMID 30473772›Full record

ReviewF1000Research2018

Recent advances in imaging and understanding interstitial cystitis.

Pradeep Tyagi, Chan-Hong Moon, Joseph Janicki, Jonathan Kaufman, Michael Chancellor, Naoki Yoshimura, Christopher Chermansky

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in F1000Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05811377 (Phenotyping Interstitial Cystitis/Bladder Pain Syndrome by ICE-MRI Bladder Permeability Assay), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05811377 completednot on this mapstarted 2023, after this paper: background citation

Phenotyping Interstitial Cystitis/Bladder Pain Syndrome by ICE-MRI Bladder Permeability Assay

TypeobservationalSponsorChristopher J Chermansky, MDRan2023 to 2025Enrolled7ConditionsIC - Interstitial CystitisArmsFerumoxytol, Gadobutrol
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Radiology of fibrosis part III: genitourinary system.Journal of translational medicine · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Recent Developments in Imaging in BPS/IC.Current bladder dysfunction reports · 2019
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Pradeep TyagiUrology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213, USA.
Chan-Hong MoonRadiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213, USA.
Joseph JanickiLipella, Pittsburgh, USA.
Jonathan KaufmanLipella, Pittsburgh, USA.
Michael ChancellorUrology, OU- Beaumont school of medicine, Royal oak, USA.
Naoki YoshimuraUrology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213, USA.
Christopher ChermanskyUrology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15213, USA.
University of Pittsburgh Medical Center · USLipella Pharmaceuticals (United States) · US

Funding

Measuring Bladder Permeability with MRI Using a Novel Contrast Agent FormulationR42DK108397 · NIDDK · LIPELLA PHARMACEUTICALS, INC. · PI KAUFMAN, JONATHAN H · 2018 to 2019
$1.2M
Measuring Bladder Permeability with MRI using a Novel Contrast Agent FormulationR41DK108397 · NIDDK · LIPELLA PHARMACEUTICALS, INC. · PI KAUFMAN, JONATHAN H · 2015 to 2015
$225k
NIDDK NIH HHS R41 DK108397NIDDK NIH HHS R42 DK108397
6 · The paper itself

Abstract

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a debilitating condition associated with intense pelvic pain and bladder storage symptoms. Since diagnosis is difficult, prevalence estimates vary with the methodology used. There is also a lack of proven imaging tools and biomarkers to assist in differentiation of IC/BPS from other urinary disorders (overactive bladder, vulvodynia, endometriosis, and prostatitis). Current uncertainty regarding the etiology and pathology of IC/BPS ultimately impacts its timely and successful treatment, as well as hampers future drug development. This review will cover recent developments in imaging methods, such as magnetic resonance imaging, that advance the understanding of IC/BPS and guide drug development.

Indexed as

AnimalsBiomarkersCystitis, InterstitialDiagnosis, DifferentialFibrosisHumansMagnetic Resonance ImagingBiomarkersbladder wallfibrosisimagingInterstitial cystitisMRIradiation

Identifiers

PMID30473772
PMCPMC6234747
OpenAlexW2900030914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.